Chain Drug Review - Cafcit cleared
February 28, 2000 -- Anew medication to treat respiratory disorders in infants has been approved by the FDA. The product, Cafcit injection, is being rolled out by Roxane...
Business Wire - APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
February 8, 2008 -- SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products,...
Business Wire - Abraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mL
August 2, 2007 -- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that its hospital-based...
Business Wire - Abraxis BioScience Reports Second Quarter 2007 Revenue of $243 Million versus $161 Million in Prior Year Period
August 9, 2007 -- Second Quarter 2007 Adjusted Net Income Per Diluted Share Increased to $0.26 versus $0.16 in the Prior Year Period; GAAP Net Income Per Diluted Share...
Chain Drug Review - Glucophage dose
May 19, 2003 -- Bristol-Myers Squibb Co. has received Food and Drug Administration approval for a 750-mg tablet of Glucophage XR, its treatment for Type 2 diabetes....
FDA Consumer - A Panoply Of Product Approvals
May 1, 2000 -- A new device that can improve blood flow to the heart by puncturing tiny therapeutic holes in places that traditional coronary artery bypass surgery...
